Intro It is December 2021. You work as a financial analyst for Merck & Co....

50.1K

Verified Solution

Question

Finance

imageimage

Intro It is December 2021. You work as a financial analyst for Merck & Co. and are tasked with the due diligence on the proposed acquisition of a biotech startup. You estimated the following cash flows for the startup: Year 2022 2023 2024 2025 2026 Expected cash flow from assets ($ million) (end of year) 77.5 116.25 151.13 181.35 199.49 After 2026, cash flows are expected to grow by 5% per year. Based on the riskiness of your industry, you think that your weighted average cost of capital is 15%. The biotech firm has 5 million shares and bonds worth $120 million outstanding. Part 1 What is the terminal value, i.e., the present value of all free cash flows from 2027 to infinity expressed in 2026-dollars (in $ million)? 0+ decimals Submit Attempt 1/5 for 2 pts. Part 2 What is the total value of the company (in $ million)? 0+ decimals Submit Attempt 1/5 for 2 pts. Part 3 What is the value per share of common stock (in $)? 0+ decimals

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students